Cargando…
Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
BACKGROUND: We determined the effects of roxadustat on the values of anemia, iron metabolism, renal function, proteinuria, and lipid metabolism and identified the associated factors of the change in hemoglobin levels after roxadustat administration in non-dialysis chronic kidney disease (CKD) patien...
Autores principales: | Hirai, Keiji, Kaneko, Shohei, Minato, Saori, Yanai, Katsunori, Hirata, Momoko, Kitano, Taisuke, Ito, Kiyonori, Ueda, Yuichiro, Ookawara, Susumu, Morishita, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992186/ https://www.ncbi.nlm.nih.gov/pubmed/36910473 http://dx.doi.org/10.3389/fmed.2023.1071342 |
Ejemplares similares
-
Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021) -
Serum Zinc Concentration Correlates With Ferritin Concentration in Patients Undergoing Peritoneal Dialysis: A Cross-Sectional Study
por: Kaneko, Shohei, et al.
Publicado: (2020) -
Factors Associated with Uremic Pruritus in Patients Undergoing Peritoneal Dialysis
por: Minato, Saori, et al.
Publicado: (2020) -
Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study
por: Kaneko, Shohei, et al.
Publicado: (2020) -
Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease
por: Matsuyama, Momoko, et al.
Publicado: (2022)